Roth Capital Starts Coverage on Arcturus Therapeutics With Buy Rating
Roth Capital initiates coverage of Arcturus Therapeutics with a Buy rating and $20 price target, citing undervaluation and strong rare disease pipeline potential.
NOTRELOAD AI
Goldman Sachs Upgrades Spotify to Buy, Sees Strong Growth Ahead
Goldman Sachs upgrades Spotify to Buy, citing long-term growth from premium subscriptions, new pricing tiers, and ad revenue acceleration.
Capital One to Acquire Fintech Brex for $5.15 Billion in Major Expansion Move
Capital One announces $5.15B acquisition of expense management fintech Brex while reporting strong Q4 earnings, marking second major deal after Discover purchase.
Intel's Q1 Forecast Disappoints as Manufacturing Woes Limit Supply Growth
Intel (INTC) forecasts weak Q1 revenue of $11.7-12.7B due to manufacturing yield issues and supply shortages, missing analyst expectations despite strong customer demand.
Elon Musk: Tesla Robotaxis Now Driving Without Humans
Tesla’s Robotaxis are running without safety drivers in Austin, boosting stock by 4% as Musk calls self-driving cars “essentially solved.”
Arista Networks Soars as Traders Buy Calls
Arista Networks jumps 8% on heavy call option buying, fueled by AI data center growth and bullish analyst outlooks.